OR WAIT null SECS
March 18, 2019
The expansion includes a new R&D laboratory and the installation of a 12,000-liter reactor at one of the company’s manufacturing facilities on its Paullo site in Milan, Italy.
February 19, 2019
The “hands-on” seminar will be held June 12–13, 2019 and will feature educational sessions and demonstrations in the company’s process laboratory.
January 03, 2019
The $252-million acquisition is expected to strengthen Cambrex’s position as a small-molecule CDMO across the drug lifecycle.
November 02, 2018
Demand for highly potent APIs continues to rise.
September 19, 2018
Evonik completed a EUR 36 million expansion of its contract-manufacturing capabilities for API and advanced intermediates in the United States and Germany.
August 01, 2018
Determining how much containment is needed for API handling requires evaluation of multiple factors.
Heightened uncertainty means CDMO executives need to play out planning scenarios.
July 24, 2018
The glass and chemical provider will expand its synthetic pharmaceutical intermediate and API production capacity at its plant in Chiba, Japan.
June 06, 2018
Under the contract, AMRI will focus on the development and manufacture of APIs and drug product for Phase I clinical studies.
April 16, 2018
Under an Innovate UK grant for a three-year project, Arcinova and the University of Nottingham will develop a continuous, flexible modular manufacturing technology platform.